Delivery Order SPE2DB20D2014-SPE2DB25FB42B
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dihydroergotamine 1 mg/ml ampule, a medication used to treat migraines. The contract has a ceiling value of $3,610.35 and runs through March 13, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dihydroergotamine 1 mg/mL Ampoules, a medication used to treat migraines. The contract has a Firm Fixed Price pricing type, a ceiling value of $1,524.90, and a period of performance through April 2025. This contract is not set aside and is considered open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,212.09 contract is for the delivery of dihydroergotamine 1 mg/ml ampules, a medication used to treat migraines. The contract has an ultimate completion date of April 14, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite...
This federal contract award, valued at $2,175.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dihydroergotamine, a medication used to treat migraines, in 1 mg/mL ampules. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of dihydroergotamine 1 mg/ml ampules. The fixed-price delivery order, valued at $4,528.95, has a completion date of January 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,348.94, is for the delivery of dihydroergotamine 1 mg/ml ampules. It is a firm fixed-price delivery order contract with a period of performance through February 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIHYDROERGOTAMINE 1 MG/ML AMPML, a pharmaceutical product. The contract has a firm fixed price of $1,524.90 and a completion date of May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation mentioned. This award is associated with a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of dihydroergotamine 4 mg/ml solution, a specialty medication, with a ceiling value of $4,927.46 and a period of performance through March 2025. The contract is a firm fixed price instrument, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,486.52 firm fixed-price delivery order contract is for the supply of dihydroergotamine 1 mg/ml ampules. The contract has an ultimate completion date of January 15, 2025 and does not utilize any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,038.16, is a Delivery Order for the supply of Dihydroergotamine 4 mg/ml Sprymyl, a specialty medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...